{"id":13225,"date":"2022-11-04T13:46:06","date_gmt":"2022-11-04T12:46:06","guid":{"rendered":"https:\/\/www.endoscopy-campus.com\/?post_type=ec-news&#038;p=13225"},"modified":"2022-11-04T13:46:07","modified_gmt":"2022-11-04T12:46:07","slug":"fifteen-year-benefits-of-screening-sigmoidoscopy-based-on-pooled-results-of-4-randomized-controlled-trials","status":"publish","type":"ec-news","link":"https:\/\/www.endoscopy-campus.com\/en\/ec-news\/fifteen-year-benefits-of-screening-sigmoidoscopy-based-on-pooled-results-of-4-randomized-controlled-trials\/","title":{"rendered":"Fifteen-Year Benefits of Screening Sigmoidoscopy, Based on Pooled Results of 4 Randomized Controlled Trials"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">This is a pooled analysis of 4 randomized controlled trials of one-time sigmoidoscopy screening in patients aged 55 to 64 years. The trials were conducted in Norway, the U.S., the U.K., and Italy.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The percentage of patients who attended screening ranged from 58% to 84%. Incidence and mortality were reported on an intent-to-treat (intent-to-screen) basis. Among 274,952 persons, the overall incidence reduction in colorectal cancer (CRC) was 21%, which was accounted for almost entirely by a reduction in distal cancer. The decrease in CRC incidence in men and women in the screening group versus those in the usual-care group was 25% in men and 16% in women. The CRC mortality reduction was 20% overall, including 27% in men and a 9% reduction in women that did not reach significance.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">There was also an all-cause mortality reduction of 2% that reached statistical significance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>This is a pooled analysis of 4 randomized controlled trials of one-time sigmoidoscopy screening in patients aged 55 to 64 years. The trials were conducted in Norway, the U.S., the U.K., and Italy.&nbsp; The percentage of patients who attended screening ranged from 58% to 84%. Incidence and mortality were reported on an intent-to-treat (intent-to-screen) basis. &#8230; <a title=\"Fifteen-Year Benefits of Screening Sigmoidoscopy, Based on Pooled Results of 4 Randomized Controlled Trials\" class=\"read-more\" href=\"https:\/\/www.endoscopy-campus.com\/en\/ec-news\/fifteen-year-benefits-of-screening-sigmoidoscopy-based-on-pooled-results-of-4-randomized-controlled-trials\/\" aria-label=\"Read more about Fifteen-Year Benefits of Screening Sigmoidoscopy, Based on Pooled Results of 4 Randomized Controlled Trials\">Read more<\/a><\/p>\n","protected":false},"template":"","categories":[1768,1769],"tags":[2058,1343,2022],"class_list":["post-13225","ec-news","type-ec-news","status-publish","hentry","category-asge-journal-scan","category-asge-kolon","tag-colon-2","tag-crc","tag-sigmoidoscopy"],"_links":{"self":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/ec-news\/13225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/ec-news"}],"about":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/types\/ec-news"}],"wp:attachment":[{"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/media?parent=13225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/categories?post=13225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.endoscopy-campus.com\/en\/wp-json\/wp\/v2\/tags?post=13225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}